Back to Feed
ClinicalTrials.gov|Clinical Trial
Prochymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)
Mesoblast, Inc.
Abstract
The objective of the present study is to establish the safety and efficacy of Prochymal® following first acute myocardial infarction. Phase: PHASE2 Status: COMPLETED Conditions: Myocardial Infarction Interventions: Prochymal®; Placebo
Keywords
Myocardial Infarction